MWP
CEMI

Meridian Wealth Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History

Meridian Wealth Partners’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-82
Closed – – 1494
2021
Q1 		$0 Buy
+82
New +$457 ﹤0.01% 1504

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Meridian Wealth Partners's CEMI Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 82 shares.

Meridian Wealth Partners first reported a position in CEMI in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Meridian Wealth Partners reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 82 Chembio diagnostics, Inc. shares in Q2 2021.
  • Meridian Wealth Partners first reported a position in Chembio diagnostics, Inc. in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's Chembio diagnostics, Inc. position peaked at $0 in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.